GEIST:UPC Searchengine

ORD_50564/2024

Celltrion Healthcare Italy S.R.L., Celltrion Healthcare Belgium SPRL, Celltrion Healthcare Finland Oy, Celltrion Healthcare Netherlands B.V., Celltrion Healthcare France SAS, Celltrion Healthcare Deutschland GmbH, Celltrion Healthcare Hungary Kft. v. Novartis AG, Genentech, Inc.

Datum
2024-09-06
Kammer
Düsseldorf (DE) Local Division
Verfahrensart
Application for provisional measures
Sprache
EN

Metadaten

Fall-IDORD_50564-2024-019af747cf8b
Aktenzeichen
RegisterzeichenORD_50564/2024
EntscheidungsreferenzORD_50564/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 23

1 Düsseldorf Local Division UPC_CFI_165/2024 Order of the Court of First Instance of the Unified Patent Court delivered on 6 September 2024 concerning EP 3 805 248 B1 Headnotes: 1. Art. 25 UPCA constitutes uniform substantive law and Art. 62 (1) UPCA uniform procedural law, which takes precedence over national patent laws and whose content is to be inter- preted independently by the Court. 2. A situation of imminent infringement may be characterised by certain circumstances which suggest that the infringement has not yet occurred , but that the potential infringer has al- ready set the stage for it to occur. The infringement is only a matter of starting the action. The preparations for it have been fully completed. These circumstances must be assessed on a case by case basis. 3. Companies  ...